Molecular epidemiology and clinical features of Klebsiella variicola bloodstream infection compared with infection with other Klebsiella pneumoniae species complex strains

Klebsiella variicola is increasingly recognized as an emerging pathogen commonly found in the environment and human gut. However, its clinical and microbiological characteristics remain poorly understood. This study provides a comprehensive analysis of K. variicola bloodstream infections (BSIs), com...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Microbiology spectrum Jg. 13; H. 6; S. e0301724
Hauptverfasser: Ohno, Tatsuya, Harada, Sohei, Saito, Hiroki, Tanii, Rimi, Komori, Kohji, Kurosawa, Miki, Wakatake, Haruaki, Kanazawa, Minoru, Ohki, Uiri, Minoura, Ayu, Yamada, Mario, Kaneko, Satsuki, Anzai, Momoko, Tsutsui, Yuto, Kuhara, Asuka, Oyanagi, Tadatomo, Tanaka, Yosuke, Takemura, Hiromu, Takeuchi, Hiroaki, Kunishima, Hiroyuki
Format: Journal Article
Sprache:Englisch
Veröffentlicht: United States American Society for Microbiology 03.06.2025
Schlagworte:
ISSN:2165-0497, 2165-0497
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Klebsiella variicola is increasingly recognized as an emerging pathogen commonly found in the environment and human gut. However, its clinical and microbiological characteristics remain poorly understood. This study provides a comprehensive analysis of K. variicola bloodstream infections (BSIs), comparing clinical and genetic features with the closely related K. pneumoniae . We identified significant differences in the prevalence of virulence genes between the two species. Notably, we observed K. variicola causing disseminated liver abscesses, similar to hypervirulent K. pneumoniae strains. These findings have important implications for accurate species identification, informing treatment strategies, and improving patient outcomes in the face of this emerging infectious threat.
Bibliographie:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
S.H. reports receiving speaker payments from MSD, Shionogi, and Pfizer, and consulting fees from Shionogi, Pfizer, and Denka outside the submitted work. The other authors declare no conflict of interest.
ISSN:2165-0497
2165-0497
DOI:10.1128/spectrum.03017-24